205 related articles for article (PubMed ID: 21175904)
21. Clinical and laboratory study of an episode of cefotetan-induced severe hemolytic anemia.
Franchini M; Piccoli PL; Gandini G; Giuffrida A; Bressan F; De Gironcoli M; Aprili G
Hematology; 2004 Feb; 9(1):65-9. PubMed ID: 14965871
[TBL] [Abstract][Full Text] [Related]
22. Tazobactam-induced haemolytic anaemia, possibly caused by non-immunological adsorption of IgG onto patient's red cells.
Broadberry RE; Farren TW; Bevin SV; Kohler JA; Yates S; Skidmore I; Poole J; Garratty G
Transfus Med; 2004 Feb; 14(1):53-7. PubMed ID: 15043594
[TBL] [Abstract][Full Text] [Related]
23. Trimethoprim-sulfamethoxazole-induced aseptic meningitis-not just another sulfa allergy.
Bruner KE; Coop CA; White KM
Ann Allergy Asthma Immunol; 2014 Nov; 113(5):520-6. PubMed ID: 25240332
[TBL] [Abstract][Full Text] [Related]
24. Prevalence and predictors of trimethoprim-sulfamethoxazole resistance among uropathogenic Escherichia coli isolates in Michigan.
Brown PD; Freeman A; Foxman B
Clin Infect Dis; 2002 Apr; 34(8):1061-6. PubMed ID: 11914994
[TBL] [Abstract][Full Text] [Related]
25. Trimethoprim-sulfamethoxazole as a viable treatment option for infections caused by methicillin-resistant Staphylococcus aureus.
Grim SA; Rapp RP; Martin CA; Evans ME
Pharmacotherapy; 2005 Feb; 25(2):253-64. PubMed ID: 15767239
[TBL] [Abstract][Full Text] [Related]
26. Hyperkalemic renal tubular acidosis induced by trimethoprim/sulfamethoxazole in an AIDS patient.
Sheehan MT; Wen SF
Clin Nephrol; 1998 Sep; 50(3):188-93. PubMed ID: 9776424
[TBL] [Abstract][Full Text] [Related]
27. Treatment of methicillin-resistant Staphylococcus aureus infections with a minimal inhibitory concentration of 2 μg/mL to vancomycin: old (trimethoprim/sulfamethoxazole) versus new (daptomycin or linezolid) agents.
Campbell ML; Marchaim D; Pogue JM; Sunkara B; Bheemreddy S; Bathina P; Pulluru H; Chugh N; Wilson MN; Moshos J; Ku K; Hayakawa K; Martin ET; Lephart PR; Rybak MJ; Kaye KS
Ann Pharmacother; 2012 Dec; 46(12):1587-97. PubMed ID: 23212935
[TBL] [Abstract][Full Text] [Related]
28. Trimethoprim/sulfamethoxazole-induced hypoglycemia in a patient with acute renal failure.
Lee AJ; Maddix DS
Ann Pharmacother; 1997 Jun; 31(6):727-32. PubMed ID: 9184713
[TBL] [Abstract][Full Text] [Related]
29. Adverse reactions to trimethoprim/sulfamethoxazole in AIDS.
Floris-Moore MA; Amodio-Groton MI; Catalano MT
Ann Pharmacother; 2003 Dec; 37(12):1810-3. PubMed ID: 14632594
[TBL] [Abstract][Full Text] [Related]
30. Hyperkalemia associated with high-dose trimethoprim-sulfamethoxazole in a patient with the acquired immunodeficiency syndrome.
Mihm LB; Rathbun RC; Resman-Targoff BH
Pharmacotherapy; 1995; 15(6):793-7. PubMed ID: 8602391
[TBL] [Abstract][Full Text] [Related]
31. Trimethoprim/sulfametrole: evaluation of the available clinical and pharmacokinetic/pharmacodynamic evidence.
Vouloumanou EK; Karageorgopoulos DE; Rafailidis PI; Michalopoulos A; Falagas ME
Int J Antimicrob Agents; 2011 Sep; 38(3):197-216. PubMed ID: 21741802
[TBL] [Abstract][Full Text] [Related]
32. [Desensitization to trimethoprim-sulfamethoxazole in patients with HIV infection].
Piketty C; Gilqouin J; Kazatchkine M
Ann Med Interne (Paris); 1996; 147(5):327-30. PubMed ID: 9033734
[TBL] [Abstract][Full Text] [Related]
33. Trimethoprim-sulfamethoxazole exposure alters ex vivo function of B lymphocytes isolated from human immunodeficiency virus-infected patients receiving Zidovudine.
Venugopalan V; Thornton AC; Steinke DT; Rapp RP; Romanelli F; Feola DJ
Pharmacotherapy; 2009 Apr; 29(4):373-82. PubMed ID: 19323617
[TBL] [Abstract][Full Text] [Related]
34. Infections during induction therapy for children with acute lymphoblastic leukemia. the role of sulfamethoxazole-trimethoprim (SMX-TMP) prophylaxis.
Rungoe C; Malchau EL; Larsen LN; Schroeder H
Pediatr Blood Cancer; 2010 Aug; 55(2):304-8. PubMed ID: 20583218
[TBL] [Abstract][Full Text] [Related]
35. Trimethoprim-sulfamethoxazole-induced hyponatremia.
Dunn RL; Smith WJ; Stratton MA
Consult Pharm; 2011 May; 26(5):342-9. PubMed ID: 21733815
[TBL] [Abstract][Full Text] [Related]
36. The association of opportunistic infections with the occurrence of trimethoprim/sulfamethoxazole hypersensitivity in patients infected with human immunodeficiency virus.
Lehmann DF; Liu A; Newman N; Blair DC
J Clin Pharmacol; 1999 May; 39(5):533-7. PubMed ID: 10234602
[TBL] [Abstract][Full Text] [Related]
37. Trimethoprim-sulfamethoxazole induced rhabdomyolysis.
Ainapurapu B; Kanakadandi UB
Am J Ther; 2014; 21(3):e78-9. PubMed ID: 23689093
[TBL] [Abstract][Full Text] [Related]
38. Intravascular haemolysis in a patient on ceftriaxone with demonstration of anticeftriaxone antibodies.
Dinesh D; Dugan N; Carter J
Intern Med J; 2008 Jun; 38(6):438-41. PubMed ID: 18613898
[TBL] [Abstract][Full Text] [Related]
39. Trimethoprim-sulfamethoxazole induced aseptic meningitis in a renal transplant patient.
Muller MP; Richardson DC; Walmsley SL
Clin Nephrol; 2001 Jan; 55(1):80-4. PubMed ID: 11200873
[TBL] [Abstract][Full Text] [Related]
40. Fatal immune haemolysis due to antibodies to individual metabolites of 5-fluorouracil.
Yürek S; Riess H; Kreher S; Dörken B; Salama A
Transfus Med; 2010 Aug; 20(4):265-8. PubMed ID: 20456688
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
